Vimarsana
Biggest News Aggregation in the World

Page 21 - Section Head News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Section Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Section Head Today - Breaking & Trending Today

NPA seizes R165m in assets from Durban businessman and others - Vimarsana News

NPA seizes R165m in assets from Durban businessman and others

The seizure is related to an ongoing criminal case implicating the nine individuals in a scam that defrauded the police before and during the 2010 FIFA World Cup.

Assets of Thoshan Panday & Co. seized - NPA ID - DOCUMENTS - Vimarsana News

Assets of Thoshan Panday & Co. seized - NPA ID - DOCUMENTS

Entities linked to businessmen were paid over R47,3m by SAPS between October 2009 and August 2010

R165m in assets seized from World Cup accommodation corruption accused - Vimarsana News

R165m in assets seized from World Cup accommodation corruption accused

Primedia Group, the parent company to leading radio brands 947, 702, Kfm 94.5, CapeTalk and Eyewitness News, today announced the appointment of Kelvin Storie as the chief intelligence officer...

NPA Asset Forfeiture Unit seizes R165m assets from World Cup accommodation corruption accused - Vimarsana News

NPA Asset Forfeiture Unit seizes R165m assets from World Cup accommodation corruption accused

The National Prosecuting Authority Asset Forfeiture Unit (NPA AFU) has obtained an order to seize assets worth some R165 million from at least nine accused in a fraud, corruption, forgery, bribery and money laundering case.

David Fleischer, MD: Benefits of Immunotherapy Product, Hopes for Future of Treatment - Vimarsana News

David Fleischer, MD: Benefits of Immunotherapy Product, Hopes for Future of Treatment

In this interview segment, Fleischer further described some of the key points about the peanut immunotherapy patch, DBV712, and the product’s phase 3 VITESSE trial.